http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1370138-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ba7b625d11f0d39b857d908a65f8428a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate | 2002-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fa4250734147231a58ec04ed3f9648a1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26ec1b2b45d4a0f366b7e199455b43a8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_417f9e72d786f2c0d277d73a0e837582 |
| publicationDate | 2003-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1370138-A1 |
| titleOfInvention | Gene therapy for neurological tissues |
| abstract | Provided is a method of delivering to neurological tissue a transforming composition or a transformed cell, the method comprising; injecting a physiologically acceptable cerebrospinal perfusion fluid into a first catheter into the cerebrospinal pathway, which cerebrospinal perfusion fluid has a gene therapy effective amount of gene therapy agent or transformed cells; withdrawing fluid at a second catheter into the cerebrospinal pathway to create a flow and flow pathway between the first and second catheters; and maintaining the flow for a period of time adapted to perfuse at least 1 CSF volume. |
| priorityDate | 2001-03-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 535.